Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant Neoplasms
|
1641 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.100 | 0.938 | 16 | 2015 | 2020 | |||||
Primary malignant neoplasm
|
1374 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.100 | 0.938 | 16 | 2015 | 2020 | |||||
Breast Carcinoma
|
2793 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.040 | 0.750 | 4 | 2015 | 2018 | |||||
Malignant neoplasm of breast
|
3417 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.040 | 0.750 | 4 | 2015 | 2018 | |||||
Malignant neoplasm of stomach
|
615 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.040 | 1.000 | 4 | 2015 | 2020 | |||||
Neoplasms
|
1644 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.040 | 1.000 | 4 | 2015 | 2017 | |||||
Stomach Carcinoma
|
652 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.040 | 1.000 | 4 | 2015 | 2020 | |||||
cervical cancer
|
268 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.030 | 1.000 | 3 | 2016 | 2018 | |||||
Cervix carcinoma
|
283 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.030 | 1.000 | 3 | 2016 | 2018 | |||||
Malignant tumor of cervix
|
245 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.030 | 1.000 | 3 | 2016 | 2018 | |||||
Secondary malignant neoplasm of lymph node
|
188 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.030 | 1.000 | 3 | 2017 | 2019 | |||||
Carcinoma of lung
|
1204 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.020 | 1.000 | 2 | 2018 | 2018 | |||||
Carcinoma, Ovarian Epithelial
|
327 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Liver carcinoma
|
942 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.020 | 1.000 | 2 | 2017 | 2020 | |||||
Malignant neoplasm of gastrointestinal tract
|
55 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.020 | 1.000 | 2 | 2016 | 2017 | |||||
Malignant neoplasm of lung
|
1142 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.020 | 1.000 | 2 | 2018 | 2018 | |||||
Malignant neoplasm of ovary
|
315 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
ovarian neoplasm
|
757 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Primary malignant neoplasm of lung
|
981 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.020 | 1.000 | 2 | 2018 | 2018 | |||||
Carcinogenesis
|
355 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.010 | 1 | 2015 | 2015 | ||||||
Extrapulmonary Small Cell Carcinoma
|
11 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Familial lichen amyloidosis
|
24 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Glioma
|
353 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.010 | 1 | 2017 | 2017 | ||||||
Head and Neck Carcinoma
|
118 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Hepatitis B
|
519 | 0.633 | 0.480 | 12 | 53966448 | intron variant | G/A | snv | 0.57 | 0.010 | 1.000 | 1 | 2017 | 2017 |